Insider Trading & Ownership - Karydas Daphne

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Karydas Daphne

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-22
Option Award
2024-05-23
4:21 pm
N/A
2034-05-22
Mineralys Therapeutics Inc.MLYSKarydas Daphne
Director
22,000$022,000
(Direct)
View
2024-05-09
Option Award
2024-05-13
06:44 am
2025-05-09
2034-05-08
COMPASS Pathways plcCMPSKarydas Daphne
Director
26,000$026,000
(Direct)
View
2023-09-18
Option Award
2023-09-20
6:58 pm
2023-10-18
2033-09-17
COMPASS Pathways plcCMPSKarydas Daphne
Director
52,000$052,000
(Direct)
View
2023-09-13
Option Award
2023-09-14
4:13 pm
N/A
2033-09-13
Mineralys Therapeutics Inc.MLYSKarydas Daphne
Director
44,000$044,000
(Direct)
View
2022-11-16
Disposition
2022-11-17
9:07 pm
N/A
2032-06-17
LogicBio Therapeutics Inc.LOGCKarydas Daphne
Director
12,500$00
(Direct)
View
2022-06-17
Option Award
2022-07-05
06:59 am
N/A
2032-06-17
LogicBio Therapeutics Inc.LOGCKarydas Daphne
Director
12,500$012,500
(Direct)
View
2021-06-11
Option Award
2021-06-14
8:00 pm
N/A
2031-06-11
LogicBio Therapeutics Inc.LOGCKarydas Daphne
Director
12,500$012,500
(Direct)
View
2021-02-03
Option Award
2021-02-05
4:22 pm
N/A
2031-02-03
Syndax Pharmaceuticals IncSNDXKarydas Daphne
Chief Financial Officer
95,000$095,000
(Direct)
View
2020-12-10
Option Award
2020-12-14
4:46 pm
N/A
2030-12-10
LogicBio Therapeutics Inc.LOGCKarydas Daphne
Director
20,000$020,000
(Direct)
View

Ownership
2020-07-13
08:28 am
N/A
2030-05-12
Syndax Pharmaceuticals IncSNDXKarydas Daphne
Chief Financial Officer
0$0215,000
(Direct)
View